Helicobacter pylori: present status and future prospects in Japan
Open Access
- 1 January 2007
- journal article
- review article
- Published by Springer Nature in The Esophagus
- Vol. 42 (1), 1-15
- https://doi.org/10.1007/s00535-006-1990-z
Abstract
The discovery of Helicobacter pylori has already changed the natural history of peptic ulcer disease, with most patients being cured at their first presentation. Similarly, the incidence of gastric cancer and other diseases related to H. pylori are likely to be greatly reduced in the near future. Isolation of the spiral intragastric bacterium H. pylori totally reversed the false dogma that the stomach was sterile, and it taught us that chronic infectious disease can still exist in modern society. Helicobacter pylori’s unique location, persistence, and evasion of the immune system offer important insights into the pathophysiology of the gut. Also, the fact that it was overlooked for so long encourages us to think “outside the box” when investigating other diseases with obscure etiologies. We should consider such provocative scientific ideas as bridges to the future disease control.Keywords
This publication has 188 references indexed in Scilit:
- Therapeutic strategies for functional dyspepsia and the introduction of the Rome III classificationThe Esophagus, 2006
- Virulent strains of Helicobacter pylori and vascular diseases: A meta-analysisAmerican Heart Journal, 2006
- Individual and joint impact of family history and Helicobacter pylori infection on the risk of stomach cancer: a nested case–control studyBritish Journal of Cancer, 2004
- The effect of antibiotic therapy for patients infected with Helicobacter pylori who have chronic urticariaJournal of the American Academy of Dermatology, 2003
- Structural definition on the surface of Helicobacter pylori type IV secretion apparatusCellular Microbiology, 2003
- Molecular characterization of mouse gastric epithelial progenitor cellsProceedings of the National Academy of Sciences, 2002
- Helicobacter pyloriInfection and the Development of Gastric CancerNew England Journal of Medicine, 2001
- Global cancer statistics in the year 2000The Lancet Oncology, 2001
- Interleukin-1 polymorphisms associated with increased risk of gastric cancerNature, 2000
- Interleukin-1 inhibits the secretion of gastric acid in rats: Possible involvement of prostaglandinBiochemical and Biophysical Research Communications, 1989